• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.

作者信息

Bhatt Deepak L, Steg P Gabriel, Miller Michael

机构信息

Brigham and Women's Hospital, Boston, MA

Assistance Publique-Hôpitaux de Paris, Paris, France.

出版信息

N Engl J Med. 2019 Apr 25;380(17):1678. doi: 10.1056/NEJMc1902165.

DOI:10.1056/NEJMc1902165
PMID:31018077
Abstract
摘要

相似文献

1
Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.二十碳五烯酸乙酯降低心血管风险。回复。
N Engl J Med. 2019 Apr 25;380(17):1678. doi: 10.1056/NEJMc1902165.
2
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.依泽替米贝降低严重高甘油三酯血症患者心血管风险
N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.
3
Cardiovascular Risk Reduction with Icosapent Ethyl.二十碳五烯酸乙酯降低心血管疾病风险
N Engl J Med. 2019 Apr 25;380(17):1678. doi: 10.1056/NEJMc1902165.
4
Cardiovascular Risk Reduction with Icosapent Ethyl.二十碳五烯酸乙酯降低心血管疾病风险
N Engl J Med. 2019 Apr 25;380(17):1677. doi: 10.1056/NEJMc1902165.
5
The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethyl.REDUCE-IT研究中心血管风险的降低归因于二十碳五烯酸乙酯中的二十碳五烯酸。
Eur Heart J. 2021 Dec 14;42(47):4865-4866. doi: 10.1093/eurheartj/ehab760.
6
Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.降低欧洲剩余心血管风险：欧洲药品管理局批准依泽替米贝/二十碳五烯酸的治疗意义。
Pharmacol Ther. 2022 Sep;237:108172. doi: 10.1016/j.pharmthera.2022.108172. Epub 2022 Mar 15.
7
Icosapent Ethyl for Primary Versus Secondary Prevention of Major Adverse Cardiovascular Events in Hypertriglyceridemia: Value for Money Analysis.依泽替米贝用于高甘油三酯血症患者一级和二级预防主要不良心血管事件的成本效果分析。
Am J Med. 2021 Jul;134(7):e415-e419. doi: 10.1016/j.amjmed.2020.12.023. Epub 2021 Jan 12.
8
Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis.依泽替米贝在他汀类药物治疗持续高甘油三酯血症的糖尿病女性患者中的血脂作用：ANCHOR 试验亚组分析。
J Womens Health (Larchmt). 2018 Sep;27(9):1170-1176. doi: 10.1089/jwh.2017.6757. Epub 2018 Mar 27.
9
Reduction of cardiovascular risk with icosapent ethyl (Vascepa).二十碳五烯酸乙酯（Vascepa）降低心血管疾病风险
Med Lett Drugs Ther. 2020 Feb 10;62(1591):17-18.
10
The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention.有充分理由将二十碳五烯酸（二十碳五烯酸乙酯）添加到心血管疾病预防的 ABC 中。
Postgrad Med. 2021 Jan;133(1):28-41. doi: 10.1080/00325481.2020.1783937. Epub 2020 Aug 6.

引用本文的文献

1
Practical Approaches to Managing Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病患者血脂异常管理的实用方法
J Lipid Atheroscler. 2025 Jan;14(1):5-29. doi: 10.12997/jla.2025.14.1.5. Epub 2024 Jun 26.
2
Lipid Disorders Management Strategies (2024) in Prediabetic and Diabetic Patients.糖尿病前期和糖尿病患者的血脂异常管理策略（2024年）
Pharmaceuticals (Basel). 2024 Feb 7;17(2):219. doi: 10.3390/ph17020219.
3
ISCHEMIA trial - a hundred million dollar 'Trial' under trial!
缺血试验——一项耗资一亿美元的“试验”正在接受审查！
Indian J Thorac Cardiovasc Surg. 2022 Sep;38(5):463-465. doi: 10.1007/s12055-022-01400-8. Epub 2022 Aug 4.
4
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.E 系列消退素代谢组、专门的促消退介质（SPM）的生物合成及其立体化学在炎症消退中的关键作用：为长期新冠、人体临床试验和靶向精准营养制备 SPM。
Semin Immunol. 2022 Jan;59:101597. doi: 10.1016/j.smim.2022.101597. Epub 2022 Feb 16.
5
EPA and DHA containing phospholipids have contrasting effects on membrane structure.含 EPA 和 DHA 的磷脂对膜结构有相反的影响。
J Lipid Res. 2021;62:100106. doi: 10.1016/j.jlr.2021.100106. Epub 2021 Aug 13.
6
A New E-Series Resolvin: RvE4 Stereochemistry and Function in Efferocytosis of Inflammation-Resolution.一种新型E系列消退素：RvE4在炎症消退的胞葬作用中的立体化学与功能
Front Immunol. 2021 Feb 10;11:631319. doi: 10.3389/fimmu.2020.631319. eCollection 2020.
7
Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses.依泽替米贝降低血管重建风险：REDCUATE-IT 血管重建分析结果。
Circulation. 2021 Jan 5;143(1):33-44. doi: 10.1161/CIRCULATIONAHA.120.050276. Epub 2020 Nov 5.
8
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid.ω-3 脂肪酸二十碳五烯酸的心血管保护作用的新机制。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1135-1147. doi: 10.1161/ATVBAHA.119.313286. Epub 2020 Mar 26.
9
Fibrate pharmacogenomics: expanding past the genome.纤维酸类药物遗传学：超越基因组。
Pharmacogenomics. 2020 Mar;21(4):293-306. doi: 10.2217/pgs-2019-0140. Epub 2020 Mar 17.
10
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States.REDCUE-IT 美国研究：3146 例美国患者随机分组结果。
Circulation. 2020 Feb 4;141(5):367-375. doi: 10.1161/CIRCULATIONAHA.119.044440. Epub 2019 Nov 11.